Pfizer/BioNTech finds Covid vaccine safe and effective for children 12 to 15

Studies show vaccine produces robust antibody responses in school-age children, companies say

The Pfizer and BioNTech pharmaceutical partnership announced on Wednesday that their Covid-19 vaccine was safe, effective and produced robust antibody responses in 12-to 15-year old children, paving the way for them to seek US authorisation within the next few weeks and from regulators in other countries swiftly thereafter.

Related: Germany restricts use of AstraZeneca jab to over-60s

Continue reading...

Coronavirus | The Guardian

Comments

Popular posts from this blog

Vaccine hesitant New Yorkers consider leaving the city as mandates take effect

Brentford manager calls for weekend shutdown in Premier League Covid fight

Coronavirus live news: AstraZeneca reports vaccine shortfall to EU; Sydney hotel quarantine worker tests positive